Haemophilus influenzae type B vaccine in children with sickle cell disease: antibody persistence after vaccination at age one and one-half to six years.
Marcinak
J F
JF
Department of Pediatrics, University of Illinois College of Medicine, Chicago.
Frank
A L
AL
Labotka
R L
RL
Rao
S
S
Frisone
L R
LR
Yogev
R
R
McVerry
P
P
D000755:Anemia, Sickle Cell / Q000150:complications*; D000907:Antibodies, Bacterial / Q000032:analysis*; D016667:Bacterial Capsules; D001428:Bacterial Vaccines; D002648:Child; D004168:Diphtheria Toxoid; D005500:Follow-Up Studies; D006192:Haemophilus Infections / Q000276:immunology*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology*; D006450:Hemoglobin SC Disease / Q000150:complications*; D006801:Humans; D007117:Immunization, Secondary; D007223:Infant; D011135:Polysaccharides, Bacterial; D013997:Time Factors
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D004168:Diphtheria Toxoid; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; C052180:Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate; D011135:Polysaccharides, Bacterial